Tags

Type your tag names separated by a space and hit enter

Menstrual migraine: a review of hormonal causes, prophylaxis and treatment.
Expert Opin Pharmacother 2007; 8(11):1605-13EO

Abstract

Migraine in some women is associated with changes in sex hormone levels. Many women suffer from increased frequency of migraine around the time of menses. Menstrual migraine (MM) may be more severe than migraine that occurs at other times of the cycle. The pathogenesis of MM is probably related to declining estrogen levels after exposure to high levels of the hormone for several days. The acute treatment of MM is similar to that of non-menstrually-related attacks. 5-HT(1B/1D) agonists (triptans), ergots, NSAIDs, or combination analgesics may be used, although the response to some drugs may not be as robust as that of non-menstrual attacks. Women who suffer from frequent or debilitating MM attacks may benefit from perimenstrual prophylaxis that can be either hormonal or non-hormonal.

Authors+Show Affiliations

Thomas Jefferson University, Department of Neurology, Philadelphia, PA 19107, USA. avi.ashkenazi@jefferson.eduNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

17685879

Citation

Ashkenazi, Avi, and Stephen Silberstein. "Menstrual Migraine: a Review of Hormonal Causes, Prophylaxis and Treatment." Expert Opinion On Pharmacotherapy, vol. 8, no. 11, 2007, pp. 1605-13.
Ashkenazi A, Silberstein S. Menstrual migraine: a review of hormonal causes, prophylaxis and treatment. Expert Opin Pharmacother. 2007;8(11):1605-13.
Ashkenazi, A., & Silberstein, S. (2007). Menstrual migraine: a review of hormonal causes, prophylaxis and treatment. Expert Opinion On Pharmacotherapy, 8(11), pp. 1605-13.
Ashkenazi A, Silberstein S. Menstrual Migraine: a Review of Hormonal Causes, Prophylaxis and Treatment. Expert Opin Pharmacother. 2007;8(11):1605-13. PubMed PMID: 17685879.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Menstrual migraine: a review of hormonal causes, prophylaxis and treatment. AU - Ashkenazi,Avi, AU - Silberstein,Stephen, PY - 2007/8/10/pubmed PY - 2007/9/18/medline PY - 2007/8/10/entrez SP - 1605 EP - 13 JF - Expert opinion on pharmacotherapy JO - Expert Opin Pharmacother VL - 8 IS - 11 N2 - Migraine in some women is associated with changes in sex hormone levels. Many women suffer from increased frequency of migraine around the time of menses. Menstrual migraine (MM) may be more severe than migraine that occurs at other times of the cycle. The pathogenesis of MM is probably related to declining estrogen levels after exposure to high levels of the hormone for several days. The acute treatment of MM is similar to that of non-menstrually-related attacks. 5-HT(1B/1D) agonists (triptans), ergots, NSAIDs, or combination analgesics may be used, although the response to some drugs may not be as robust as that of non-menstrual attacks. Women who suffer from frequent or debilitating MM attacks may benefit from perimenstrual prophylaxis that can be either hormonal or non-hormonal. SN - 1744-7666 UR - https://www.unboundmedicine.com/medline/citation/17685879/full_citation L2 - http://www.tandfonline.com/doi/full/10.1517/14656566.8.11.1605 DB - PRIME DP - Unbound Medicine ER -